Interview with Fangchen Lee, Chairman, Yung Shin Group
Yung Shin has a very long and well-regarded history here in Taiwan. Perhaps we could start by you telling our readers about the recent history of the company and its…
Address: 1191, Sec. 1, Chung Shan Rd. Tachia, Taichung, Taiwan 43744, Republic Of China
Tel: +886-4-2687-5100
For years Yung Shin has been upholding the philosophy of service, honest and innovation and today is a comprehensive international pharmaceutical and healthcare group. Yung Shin has always insisted on its corporate belief that ‘a company improves people’s health by providing the best pharmaceuticals,’ and has treated customer satisfaction as its priority. In the future, Yung Shin will focus on taking the quality of its products to a higher level, and deepen its international competitiveness and global marketing with the foundations it has built overseas over the past years, in order to reach its goal of becoming a dedicated global entity.
Future expansion plans include expanding the company’s business territories with dedicated technologies, and aim to reach the world from the company’s base in Taiwan.
Yung Shin has a very long and well-regarded history here in Taiwan. Perhaps we could start by you telling our readers about the recent history of the company and its…
Nutrarex Biotech is a Taiwanese private label contract manufacturer of functional supplements, exclusively representing a number of cutting-edge raw materials from Europe, the US, and Japan. Stanley Huang is the…
In an effort to enhance trade and cooperation with other countries in the region and reduce dependency on mainland China, in 2016 Taiwan’s government introduced the New Southbound Policy (NSP).…
Within Taiwan’s evolving medical device sector, many innovative startups are exploring breakthrough ideas which are sparking global interest and attention – iXensor being a chief example. The company’s patented technology…
Mark Yang, CEO of GaleMed, elaborates on the medical device manufacturer’s transition from a privately-owned company to being acquired by private equity firm Nexus Point Capital. Yang goes on to…
United Biomedical, Inc. (UBI) is dedicated to the discovery, development, and commercialization of immunotherapies & vaccines for chronic and infectious diseases and is passionate about delivering science-driven innovation with platform…
James Chiu, GM of Fresenius Kabi Taiwan, discusses the affiliate’s portfolio offering of parenteral and enteral nutrition in Taiwan as well as its move towards biosimilars. In addition, Chiu highlights…
Shuhei Sekiguchi, recently-appointed managing director of Janssen Taiwan, discusses how his vast experience in marketing and sales will help him in this new role, Janssen´s market outlook for Taiwan, its…
The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalized healthcare – a strategy that aims to fit the right treatment to each…
G-SYN Biomedical Technology is a company dedicated to resolving problems occurring from cell hypoxia. Dieter Chang, the company’s founder introduces the firm, why they decided to focus on hypoxia, their…
Philip Chen, chairman of the Taipei Exchange, discusses the capital market condition, elaborates on the significance of biotech, and shares the competitive advantages of innovation companies listing on TPEx. Chen…
Danny Liao, CEO of Taiwanese diagnostics firm Skyla discusses the reason behind splitting from parent company Lite-On, the thinking behind a move from information technology (IT) into medical diagnostics and…
The Southern Taiwan Science Park (STSP)’s Chen-Kang Su discusses how STSP has played a key role in bringing innovation to Taiwan, how collaborations between academic institutions and industry are helping…
See our Cookie Privacy Policy Here
